Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 3
2008 2
2009 6
2010 9
2011 7
2012 6
2013 15
2014 6
2015 9
2016 10
2017 6
2018 2
2019 4
2020 7
2021 5
2022 7
2023 2
2024 6
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
O'Bryan JP, Piazza GA. O'Bryan JP, et al. Among authors: piazza ga. Adv Cancer Res. 2022;153:xiii-xiv. doi: 10.1016/S0065-230X(22)00012-4. Adv Cancer Res. 2022. PMID: 35101237 No abstract available.
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone.
Coley AB, Ward A, Keeton AB, Chen X, Maxuitenko Y, Prakash A, Li F, Foote JB, Buchsbaum DJ, Piazza GA. Coley AB, et al. Among authors: piazza ga. Adv Cancer Res. 2022;153:131-168. doi: 10.1016/bs.acr.2021.07.009. Epub 2021 Aug 26. Adv Cancer Res. 2022. PMID: 35101229 Review.
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer.
Foote JB, Mattox TE, Keeton AB, Chen X, Smith F, Berry KL, Holmes T, Wang J, Huang CH, Ward AB, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G, Nurmemmedov E, Babic I, Gaponenko V, Abdelkarim H, Boyd MR, Gorman GS, Manne U, Bae S, El-Rayes BF, Piazza GA. Foote JB, et al. Among authors: piazza ga. bioRxiv [Preprint]. 2024 Oct 7:2023.05.17.541233. doi: 10.1101/2023.05.17.541233. bioRxiv. 2024. Update in: Cancer Res. 2024 Dec 19. doi: 10.1158/0008-5472.CAN-24-0323. PMID: 38328254 Free PMC article. Updated. Preprint.
Validation of PDE5 as a Chemoprevention Target.
Piazza GA. Piazza GA. Cancer Prev Res (Phila). 2017 Jul;10(7):373-376. doi: 10.1158/1940-6207.CAPR-17-0136. Epub 2017 Jun 9. Cancer Prev Res (Phila). 2017. PMID: 28600399 Free PMC article. No abstract available.
Assessment of KRASG12C inhibitors for colorectal cancer.
Piazza GA, Chandrasekaran P, Maxuitenko YY, Budhwani KI. Piazza GA, et al. Front Oncol. 2024 Jun 24;14:1412435. doi: 10.3389/fonc.2024.1412435. eCollection 2024. Front Oncol. 2024. PMID: 38978742 Free PMC article. Review.
Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer.
Patergnani S, Buchsbaum DJ, Piazza GA. Patergnani S, et al. Among authors: piazza ga. Front Oncol. 2022 Sep 13;12:1022174. doi: 10.3389/fonc.2022.1022174. eCollection 2022. Front Oncol. 2022. PMID: 36176399 Free PMC article. No abstract available.
MicroRNA and cancer chemoprevention.
Yi B, Piazza GA, Su X, Xi Y. Yi B, et al. Among authors: piazza ga. Cancer Prev Res (Phila). 2013 May;6(5):401-9. doi: 10.1158/1940-6207.CAPR-13-0032. Epub 2013 Mar 26. Cancer Prev Res (Phila). 2013. PMID: 23531448 Free PMC article. Review.
The RAS-Effector Interaction as a Drug Target.
Keeton AB, Salter EA, Piazza GA. Keeton AB, et al. Among authors: piazza ga. Cancer Res. 2017 Jan 15;77(2):221-226. doi: 10.1158/0008-5472.CAN-16-0938. Epub 2017 Jan 6. Cancer Res. 2017. PMID: 28062402 Free PMC article. Review.
NSAIDs inhibit tumorigenesis, but how?
Gurpinar E, Grizzle WE, Piazza GA. Gurpinar E, et al. Among authors: piazza ga. Clin Cancer Res. 2014 Mar 1;20(5):1104-13. doi: 10.1158/1078-0432.CCR-13-1573. Epub 2013 Dec 5. Clin Cancer Res. 2014. PMID: 24311630 Free PMC article. Review.
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma.
Reddy Bandi DS, Nagaraju GP, Sarvesh S, Carstens JL, Foote JB, Graff EC, Fang YD, Keeton AB, Chen X, Berry KL, Bae S, Akce M, Gorman G, Yoon KJ, Manne U, Boyd MR, Buchsbaum DJ, Azmi AS, Maxuitenko YY, Piazza GA, El-Rayes BF. Reddy Bandi DS, et al. Among authors: piazza ga. bioRxiv [Preprint]. 2024 Oct 8:2024.10.04.616725. doi: 10.1101/2024.10.04.616725. bioRxiv. 2024. PMID: 39416034 Free PMC article. Preprint.
108 results